Kura Oncology says SVB liquidity concern exposure immaterial

Kura Oncology, Inc.

Kura acknowledges media reports of a possible liquidity concern at Silicon Valley Bank.
Company states its exposure to any SVB liquidity issue is immaterial.
No financial impact or operational disruption expected from the situation.

item 7.01

Kura Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-067513

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.